Phytanic acid is a derivative of the phytol side-chain of chlorophyll. It appears in humans following the ingestion of fatcontaining foods and is present in human blood at a low micromolar concentration. It may activate retinoid X receptors (RXR) or peroxisome proliferator-activated receptor (PPAR) a in vitro. Phytanic acid induced the adipocyte differentiation of 3T3-L1 cells in culture as assessed by accumulation of lipid droplets and induction of the aP2 mRNA marker. This effect was mimicked by a synthetic activator of RXR but not by a PPARa agonist or by palmitic acid. In human pre-adipocytes in primary culture, phytanic acid also induced adipocyte differentiation. These findings indicate that phytanic acid may act as a natural rexinoid in adipose cells and suggest a potential use in the treatment of human type 2 diabetes and obesity.
Introduction
Phytanic (3,7,11,15-tetramethylhexadecanoic) acid is a derivative of the phytol side chain of chlorophyll. In humans it appears either following ingestion of fat-containing foods of animal origin or oxidation of the phytol from animal or vegetable foods. It is metabolized in peroxisomes which requires a specific enzyme, phytanoyl-CoA hydroxylase. Lack of this enzyme causes Refsum disease. 1 In the search for natural products that could activate nuclear hormone receptors, phytanic acid was found to be capable of binding and activating retinoid X receptor (RXR) 2 and peroxisome proliferator-activated receptor (PPAR) a. 3 Although the affinity of phytanic acid for RXR and PPARa was lower than 9-cis-retinoic acid or fibrates, respectively, phytanic acid levels in human blood are in the micromolar range, 4 which is compatible with a physiological role for this molecule. Drugs that activate RXR or PPARa have a marked impact on whole body metabolism and act as insulin-sensitizers or hypolipidemic agents, respectively. 5, 6 Thus, phytanic acid appears as a natural product with potential effects on metabolic disorders such as diabetes or obesity. However, to date few studies have assessed the influence of phytanic acid on gene expression or physiology. We have reported that phytanic acid promotes the expression of the uncoupling protein-1 gene and activates brown adipocyte differentiation. 7 However, phytanic acid not only activated gene markers specific to brown adipocyte such as uncoupling protein-1 but also gene markers common to brown and white adipocytes. Considering the differential roles of brown and white adipose tissue (energy expenditure by thermogenesis and energy storage, respectively) and the minor metabolic relevance of brown fat in adult humans, we attempted to establish whether white adipocyte is a target of phytanic acid and to examine the effects of this fatty acid on white adipocyte differentiation.
Methods
Phytanic acid, dexamethasone (DEX), 3-isobutyl-l-methylxantine (IBMX), insulin, palmitic acid, Wy 14,643, D-biotine and Na-panthotenate were from Sigma. AGN19420 and BRL49653 were gifts from Dr Chandraratna (Allergan, Irvine, USA) and Dr L Casteilla, (University of Toulouse, France), respectively. 3T3-L1 preadipocytes were maintained in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum (FCS). At confluence cells were induced to differentiate by a 2 day treatment with DMEM supplemented with 10% FCS, 10 mg=ml insulin, 0.5 mM IBMX and 1 mM DEX (differentiating medium). Thereafter, cells were maintained in DMEM supplemented with 10% FCS only. When indicated, exposure to the differentiation medium was suppressed and cells were maintained after confluence in the medium containing DMEM plus 10% FCS. Cells were studied 1 week or 2 weeks after treatment with differentiation medium or non-differentiation medium to which phytanic acid had been added or not. Phytanic acid was dissolved in dimethylsulfoxide and controls included the equivalent amount of solvent, always less than 1 : 1000 the volume of culture medium. The appearance of cytoplasmatic lipid droplets was monitored by bright-field microscopy after staining with Oil-Red O 8 and the percentage of cells showing lipid droplets was quantified. Total RNA was extracted using an affinity column-based method (Qiagen, Germany). Samples (20 mg) of RNA were analyzed by Northern blot and probed with the aP2 cDNA labeled by [a-32 P]dCTP (Amersham). Ribosomal RNA stained with ethidium bromide was used to confirm equal loading of samples. Human preadipocytes were obtained from Zen-Bio (Research Triangle Park, USA). They were cultured in DMEM=Ham's F12 medium (1 : 1, vol=vol) supplemented with 10% FCS and, when confluent, differentiation was induced by 3 day culture with DMEM=Ham's F12 medium supplemented with 3% FCS, 10 mg=ml insulin, 33 mM D-biotine, 17 mM Na-panthotenate, 1 mM DEX, 0.5 mM IBMX and 1 mM BRL49653. Cells were incubated thereafter in medium without IBMX and BRL49653 for 2 weeks. When indicated BRL49653 was withdrawn from the differentiation -induction medium and replaced or not by 80 mM phytanic acid. The extent of adipocyte differentiation was estimated as for 3T3-L1 cell cultures.
Results and discussion
When 3T3-L1 cells were treated with the differentiating medium more than 85% of cells accumulated lipids and acquired the adipose cell morphology 1 week after induction ( Figure 1A ). When confluent 3T3-L1 cells were cultured without the treatment with the differentiation-inducing medium, cells did not differentiate. The addition of phytanic acid to this non-differentiating medium resulted in around 50% (40 mM) or 65% (80 mM) of cells becoming adipocytes. When cells were cultured for a further week, around 70% of cells treated with 40 mM phytanic became adipocytes and more than 85% of cells treated with 80 mM phytanic acid acquired adipocyte morphology. The effect observed was not common to any fatty acid: exposure of 3T3-L1 cells to 80 mM palmitic acid did not promote differentiation. The effects of phytanic acid were also assessed using aP2 mRNA expression as a gene marker of adipocyte differentiation ( Figure 1B ). aP2 mRNA levels were high in differentiated 3T3-L1 adipocytes whereas, in cells that were not allowed to differentiate into adipocytes, aP2 mRNA expression was undetectable. Exposure to 80 mM phytanic acid induced aP2 mRNA expression in parallel with the acquisition of the adipocyte morphology. A positive effect was also induced by 1 mM AGN19420, a specific RXR activator ( Figure 1B ). Wy 14,643, a PPARa activator, had no effect (not shown). Moreover, as for morphology, no major effects were induced by treatment with palmitic acid, which led to a slight increase in aP2 mRNA expression.
The identification of a novel natural agent capable of promoting white adipose differentiation could be relevant for the treatment of human disorders. Therefore, the effects of phytanic acid were studied using primary cultures of human white adipose precursor cells. Human white adipose Chlorophyll-derived metabolite phytanic acid A Schlüter et al pre-adipocytes were cultured in the optimal conditions for differentiation (see Methods) which required supplementation of the culture medium with BRL49653, a PPARg activator. In this cell model, the absence of BRL49653 suppressed the capacity of pre-adipocytes to differentiate into adipocytes ( Figure 2 ). When phytanic acid was added to the medium instead of BRL49653, cells again acquired adipocyte morphology, although to a lesser extent (65%) respect to differentiation obtained with the optimal conditions. In conclusion, phytanic acid has a positive action on white adipocyte differentiation both in an established murine cell line, 3T3-L1, and in primary cultures of human white preadipocytes. The doses used here to show the effects of phytanic acid are in an upper range of the physiological levels in humans. 4 However, the amount of phytanic acid added to cultures that enters the pre-adipose cell may be much lower due to the binding of the fatty acid to proteins in the culture medium and to the potential requirement of saturable fatty acid transport systems. Moreover, the effects observed may involve the action of compounds derived from phytanic acid metabolism inside the cell. Finally, the extent of the exposure of white adipose tissue to phytanic acid in vivo may depend not only on circulating levels but also on local production. Most of the body's phytanic acid is stored in white adipose tissue as triacylglycerol esters of phytanic acid. As a consequence of lipolysis, free phytanic acid could appear and a transient high local exposure to phytanic acid in white adipose tissue could be expected.
Phytanic acid is likely to activate white adipocyte differentiation by acting as a natural rexinoid. The known positive effects of rexinoids on adipogenesis are caused by the activation of the RXR moiety of the RXR=PPARg heterodimer, a master transcription factor for adipocyte differentiation. 9 Phytanic acid does not appear to play its adipogenic role by its capacity to activate PPARa. 2 White adipocytes or preadipocytes express very low levels of PPARa and, in any case, even high-affinity synthetic PPARa activators are poorly adipogenic. 10 Synthetic rexinoids have insulin sensitizing properties in vivo similarly to thiazolidinediones. 5 However, rexinoids also show anti-obesity effects that are not shared by PPARg agonists. 11 In agreement with recent hypotheses, 12 the effects of phytanic acid promoting white adipocyte differentiation by a mechanism similar to synthetic rexinoids should lead to further research to explore the potential use of phytanic acid or precursor molecules as natural products for treatment of human type 2 diabetes and obesity. Figure 2 Effects of phytanic acid on human pre-adipocyte differentiation in primary culture. Microphotographs of cells two weeks after induction of differentiation with differentiating medium, with medium devoid of BRL49653 (non-differentiating medium) and with medium devoid of BRL49653 supplemented with 80 mM phytanic acid (nondifferentiating medium þ phytanic acid). The scale bar corresponds to 100 mm.
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